Ophthalmoscopy: a "blind spot" in clinical assessment of hypertensive emergencies

John Gillespie
DOI: https://doi.org/10.1136/bmj.q2338
2024-10-28
BMJ
Abstract:Miller and colleagues' review emphasises the importance of assessing for end organ damage in hypertensive emergencies.1As a foundation doctor, a "blind spot" in my practice is my inability to perform direct ophthalmoscopy in patients presenting with non-specific visual changes and a systolic blood pressure over 180 mm Hg. As the review states, the clinical findings of microaneurysms or papilledema would necessitate immediate blood pressure reduction with an intravenous agent. Unlike in other organs, there are no biochemical markers for ophthalmic insult, making competent ophthalmoscopy a crucial component in the initial clinical assessment.Despite the General Medical Council's requirement that all doctors be proficient in ophthalmoscopy,2 many lack confidence in performing this skill. A 2011 survey found that only 38% of UK medical schools formally assessed direct ophthalmoscopy before graduation.3 This lack of confidence is not confined to junior colleagues: numerous studies have identified that experienced senior clinicians are unable to detect...
medicine, general & internal
What problem does this paper attempt to address?